In accordance with our results, Takei et al. reported that inhibition of midkine secretion and expression using siRNA in prostate cancer PC-3 cells leads to significant suppression of tumor growth in a xenograft model [21]. The gene discussed is MDK; the disease is prostate carcinoma.